32025R1490

Este documento es un extracto de la web EUR-Lex

EUROPA
EUR-Lex Inicio
Implementing regulation - EU - 2025/1490 - ES - EUR-Lex

Ayuda

Consejos de búsqueda

¿Necesita más opciones de búsqueda? Utilice la Búsqueda avanzada

Documento 32025R1490

Ayuda

Commission Implementing Regulation (EU) 2025/1490 of 24 July 2025 amending Implementing Regulation (EU) No 564/2013 as regards the adaptation of fees to inflation

C/2025/4934

OJ L, 2025/1490, 25.7.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/1490/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Estatuto jurídico del documento Vigente

ELI: http://data.europa.eu/eli/reg_impl/2025/1490/oj

HTML

PDF – DO auténtico

Firma electrónica

Cómo verificar la autenticidad del Diario Oficial

Official Journal
of the European Union

L series

2025/1490

25.7.2025

COMMISSION IMPLEMENTING REGULATION (EU) 2025/1490

of 24 July 2025

amending Implementing Regulation (EU) No 564/2013 as regards the adaptation of fees to inflation

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 80(1) thereof,

Whereas:

(1)	In accordance with Article 17 of Commission Implementing Regulation (EU) No 564/2013 (2), the fees provided for in that Regulation are to be reviewed annually by reference to the inflation rate as measured by means of the European Index of Consumer Prices as published by Eurostat.

(2)	In order to perform this annual review for the year 2024, the fees should be adjusted in accordance with the average annual inflation rates for 2021, 2022 and 2023, as published by Eurostat, so as to reflect the cumulative inflation rate of 19,5 %.

(3)	Implementing Regulation (EU) No 564/2013 should therefore be amended accordingly.

(4)	The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,

HAS ADOPTED THIS REGULATION:

Article 1

Regulation (EU) No 564/2013 is amended as follows:

(1)	Annexes I and II are amended in accordance with Annex I to this Regulation;

(2)	Annex III is replaced by the text set out in Annex II to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 24 July 2025.

For the Commission

The President

Ursula VON DER LEYEN

(1) OJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528/oj.

(2) Commission Implementing Regulation (EU) No 564/2013 of 18 June 2013 on the fees and charges payable to the European Chemicals Agency pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products (OJ L 167, 19.6.2013, p. 17, ELI: http://data.europa.eu/eli/reg_impl/2013/564/oj).

ANNEX I

Annexes I and II of Regulation (EU) No 564/2013 are amended as follows:

(1)

in Annex I, Table 1 is replaced with the following:

‘Table 1

Standard fees

General description of task; relevant provision in Regulation (EU) No 528/2012	Specific condition or task description	Fee (EUR)
Approval of an active substance; Article 7(2)	Fee for the first product-type for which that active substance is approved	143 400
	Additional fee per additional product-type	47 800
	Additional fee per product-type (for both the first product-type and any additional product-type) if the active substance is a candidate for substitution in accordance with Article 10 of Regulation (EU) No 528/2012	23 900
	Fee for the amendment of an approval, other than the addition of a product-type	23 900
Renewal of an approval; Article 13(3)	Fee for the first product-type for which renewal of that active substance is sought	17 925
	Additional fee per additional product-type	1 793
	Additional fee for the first product-type for which renewal of that active substance is sought in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012	29 875
	Additional fee per additional product-type in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012	2 988
	Additional fee per product-type (for both the first product-type and any additional product-type) if the active substance is a candidate for substitution in accordance with Article 10 of Regulation (EU) No 528/2012	23 900
Inclusion in Annex I of an active substance; Article 28	Fee for the first inclusion in Annex I of an active substance	11 950
	Fee for the amendment of an inclusion of an active substance in Annex I	2 390
Notification in accordance with Article 17(4) of Commission Delegated Regulation (EU) No 1062/2014 (1)	Fee per substance/product-type combination. The fee for the notification shall be deducted from the subsequent application for approval	11 950

(2)

in Annex II, Table 1 is replaced with the following:

‘Table 1

Standard fees

General description of task; relevant provision in Regulation (EU) No 528/2012	Specific condition or task description	Fee (EUR)
Granting of Union authorisation, single product; Article 43(2)	Fee per product not identical with (one of) the representative product(s) assessed for the purpose of the substance approval	95 600
	Fee per product identical with (one of) the representative product(s) assessed for the purpose of the substance approval	47 800
	Additional fee per product when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required	47 800
	Additional fee per product when the requested authorisation is provisional in accordance with Article 55(2) of Regulation (EU) No 528/2012	11 950
Granting of Union authorisation, biocidal product family; Article 43(2)	Fee per family	179 250
	Additional fee per family when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required	71 700
	Additional fee per family when the requested authorisation is provisional in accordance with Article 55(2) of Regulation (EU) No 528/2012	17 925
Notification to the Agency of an additional product within a biocidal product family; Article 17(6)	Fee per additional product	2 390
Union authorisation of a same biocidal product; Article 17(7)	Fee per product constituting a ‘same product’ within the meaning of Commission Implementing Regulation (EU) No 414/2013 (2)	2 390
Major change of an authorised product or product family; Article 50(2)	Fee per application	47 800
Minor change of an authorised product or product family; Article 50(2)	Fee per application	17 925
Administrative change of an authorised product or product family; Article 50(2)	Fee per notification	2 390
Recommendation on the classification of a change of an authorised product or product family; Article 50(2)	Fee per request in accordance with Commission Implementing Regulation (EU) No 354/2013 (3) If the recommendation is to classify the change as an administrative or minor change, the fee for the request shall be deducted from the subsequent application or notification in accordance with Implementing Regulation (EU) No 354/2013	2 390
Renewal of Union authorisation, single product; Article 45(3)	Fee per product	5 975
	Additional fee per product in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012	17 925
	Additional fee per product when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required	47 800
Renewal of Union authorisation, biocidal product family; Article 45(3)	Fee per product family	8 963
	Additional fee per product family in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012	26 888
	Additional fee per product family when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required	71 700

(1) Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 294, 10.10.2014, p. 1, ELI: http://data.europa.eu/eli/reg_del/2014/1062/oj).’

(2) Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 125, 7.5.2013, p. 4., ELI: http://data.europa.eu/eli/reg_impl/2013/414/oj).

(3) Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 109, 19.4.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/354/oj).’

ANNEX II

‘ANNEX III

Other fees

General description of task; relevant provision in Regulation (EU) No 528/2012	Specific condition or task description	Fee (EUR)
Technical equivalence; Article 54(3)	Fee, when difference between the active substance sources is limited to a change in manufacturing location, and application is based solely on analytical data	5 975
	Fee, when difference between the active substance sources goes beyond a change in the manufacturing location, and application is based solely on analytical data	23 900
	Fee when previous conditions are not met.	47 800
Annual fee for biocidal products authorised by the Union; Article 80(1)(a)	Fee per Union authorisation of a biocidal product	11 950
	Fee per Union authorisation of a biocidal product family	23 900
Mutual Recognition Submission fee; Article 80(1)(a)	Fee per product or product family concerned by an application for mutual recognition, per Member State where mutual recognition is sought	837
Appeal; Article 77(1)	Fee per appeal	2 988
Submission for inclusion in the list of relevant persons; Article 95	Fee per submission of a letter of access to a dossier already found complete by the Agency or an evaluating Competent Authority	2 390
	Fee per submission of a letter of access to part of a dossier already found complete by the Agency or an evaluating Competent Authority, together with complementary data	23 900
	Fee per submission of a new dossier	47 800
Requests under Article 66(4) submitted to the Agency	Fee per item for which confidentiality is requested	1 195

’

ELI: http://data.europa.eu/eli/reg_impl/2025/1490/oj

ISSN 1977-0677 (electronic edition)

Arriba

Elija las funciones experimentales que desea probar